Document:

EXHIBIT 10.1

 

 

PATENT
LICENSE ASSET PURCHASE AGREEMENT

 

 

THIS
PATENT LICENSE ASSET PURCHASE AGREEMENT (the “Agreement”) is made this 15th day of December
2016, (the “Effective Date”) by and between Nexeon MedSystems Inc. a Nevada corporation, (the “Company”),
and William M. Rosellini, an individual, (“Rosellini”) (collectively the “Parties”).

 

RECITALS

 

WHEREAS,
Rosellini currently owns a Patent License obtained from Magnus IP GmbH, a German corporation, (the “License”); and

 

WHEREAS,
Rosellini wishes to sell and assign the License to the Siemens Patents and the Company wishes to acquire the License.

 

NOW
THEREFORE, in consideration of the transfer of the License to the Company and the Company’s restricted Common Stock being
issued to Rosellini along with other good and valuable consideration, the receipt and adequacy of which is hereby acknowledged,
the Company and Rosellini hereby agree as follows:

 

		1.	(a)
                                         Rosellini hereby sells, assigns, and transfers unto the Company, any and all of his right,
                                         title and interest, in and to the License owned by him related to the Siemens Patents.
                                         The License is attached hereto as Exhibit “A” and by this reference is made
                                         a part hereof and incorporated herein.

 

(b)
In consideration of 1(a) herein above the Company shall pay to Rosellini the sum of three million one hundred nineteen
thousand dollars ($3,119,000) in the form of $140,000 in cash and 2,860,000 shares of the Company’s restricted
Common Stock.

 

		2.	Rosellini
                                         Representations and Warranties. Rosellini hereby represents and warrants:

 

i)
  that he has the legal right and authority to execute this Agreement, and to validly assign their entire interest in and to the
License to the Company and that there are no liens, claims or encumbrances against the License, and

 

ii)
  that he has not executed any other agreement that would conflict with the terms of this Agreement, nor shall he execute any such
agreement in the future.

 

		3.	Further
                                         Actions. Rosellini hereby agrees to execute any further agreements and to take any
                                         further actions necessary to aid the Company in perfecting its interest in the License
                                         and in enforcing any and all protections or privileges deriving from the licensed patents.

 

		4.	Governing Law. This Agreement shall be construed in accordance with, and governed in all respects by, the laws of the State
of Nevada, without regard to conflicts of law principles.

 

    	1

    	 

    

 

 

	5.	Counterparts. This Agreement may be executed in several counterparts, each of which shall constitute an original
    and all of which, when taken together, shall constitute one agreement.

 

		6.	Severability.
                                         If any part or parts of this Agreement shall be held unenforceable for any reason, the
                                         remainder of this Agreement shall continue in full force and effect. If any provision
                                         of this Agreement is deemed invalid or unenforceable by any court of competent jurisdiction,
                                         and if limiting such provision would make the provision valid, then such provision shall
                                         be deemed to be construed as so limited.

 

		7.	Headings.
                                         The headings for section herein are for convenience only and shall not affect the meaning
                                         of the provisions of this Agreement.

 

		8.	Entire
                                         Agreement. This Agreement constitutes the entire agreement between the Company and
                                         Rosellini, and supersedes any prior understanding or representation of any kind preceding
                                         the date of this Agreement. There are no other promises, conditions, understandings or
                                         other agreements, whether oral or written, relating to the subject matter of this Agreement.

 

 

IN
WITNESS WHEREOF, the parties have caused this Agreement to be executed the day and year first above written.

 

	COMPANY:	 	ROSELLINI:
	 	 	 
	Nexeon MedSystems Inc.	 	William M Rosellini
	 	 	 
	 	 	 
	/s/
    Ronald Conquest	 	/s/
    William M Rosellini
	Name:
                                Ronald Conquest

                                Its:
                                COO
	 	Name: William M Rosellini

 

 

    	2

    	 

    

 

EXHIBIT
A

 

Magnus
License

 

 

 

    	1

    	 

    

 

LICENSE
AGREEMENT

 

This
License Agreement (this “Agreement”) is made and entered into as of September 29, 2016 (the “Effective
Date”) by and between Magnus IP GmbH, incorporated and existing under the laws of Germany, with its registered office
at Barer Strasse 9, D-80333 München (“Licensor”) and Will Rosellini, a Puerto Rican resident, residing
at 77 Arrecife, Dorado, PR 00646 (“Licensee”). Licensor and Licensee are individually referred to herein as
a “Party,” and collectively as the “Parties.”

 

WITNESSETH

 

WHEREAS, Licensor owns the Licensed
Patents (as defined below);

 

WHEREAS, Licensee
is engaged in the business of researching and developing, marketing and selling Licensed Products (as defined below);

 

WHEREAS, Licensee
desires to license the Licensed Patents and Licensor agrees to license the Licensed Patents to Licensee, pursuant to the terms
and conditions hereinafter set forth;

 

WHEREAS, the Licensed
Patents include "Necessary Claims" as defined in the Zigbee Alliance Intellectual Property Rights Policy (“Zigbee
IPR”);

 

WHEREAS, the Parties
have negotiated and agree that the terms and conditions set forth herein constitute a RAND License in compliance with the Zigbee
IPR.

 

NOW, THEREFORE,
in consideration of the above premises and mutual covenants hereinafter contained, the Parties agree as follows:

 

SECTION 1:
DEFINITIONS

 

As used in this
Agreement, the following terms shall have the following meanings:

 

“Affiliate”
means, with respect to a Party, any Person that directly or indirectly, Controls, is Controlled by or is under common Control with
such Party. For purposes of this Agreement, “Control” of an entity means ownership, directly or indirectly,
of fifty percent (50%) or more of the voting equity of such entity or, in the case of a non-corporate entity, equivalent interests.
Notwithstanding the foregoing, with respect to Licensee, the term “Affiliate” excludes any Person (i) that would solely
be an Affiliate of Licensee due to the fact that such Person is a Licensee investor, equity or other interest holder (a “Licensee
Investor”) or is a Person Controlled by, Controlling or under common Control with a Licensee Investor; or (ii) that is
a party to a pending patent infringement claim or lawsuit filed by Licensor with respect to any of the Licensed Patents at such
time, following the Effective Date, as the Person falls within the definition of Affiliate. For the avoidance of doubt, as of the
Effective Date, Rosellini Scientific Benelux, SPRL and Nexeon Medsystems, Inc. are Affiliates of Licensee.

 

“Covered
Third Party Products” means (i) Third Party products provided to a Licensee and/or its Affiliates for the benefit of
Licensee and/or its Affiliates and constituting a component or element of a Licensed Product; and (ii) Third Party products and
services that include as an essential element thereof a Licensed Product.

 

    	1

    	 

    

 

“Licensee
Third Parties” means, vendors, suppliers, distributors, contractors, customers and end-users of Licensee and its Affiliates
with respect to the Licensed Products.

 

“Licensed
Patents” means (i) the Patents listed on the attached Exhibit A; (ii) all divisions, continuations, continuations-in-part,
reissues and reexaminations or extensions of the Patents listed in (i) (whether U.S. or foreign); and (iii) no others. Licensed
Patents does not include any Patents owned or controlled by any Affiliate of Licensor.

 

“Licensed
Products” means any medical device, system, or method designed, developed, marketed, and sold by Licensee that, in the
absence of this Agreement, would infringe at least one claim of the Licensed Patents.

 

“Patents”
means (i) all classes and/or types of patents throughout the world, including utility patents, utility models, design patents,
invention certificates, reexamination certificates, reissues and renewals as well as foreign equivalents thereof; and (ii) all
applications (including provisional and non-provisional applications), continuations, divisionals, continuations-in-part, reissues,
renewals, re-examinations, as well as foreign equivalents thereof. The term “Patents” does not include any copyrights,
trademarks, mask work rights, or trade secret rights. The term “Patent” may be used to refer to one of such Patents.

 

“Person”
means a trust, corporation, partnership, joint venture, limited liability company, association, unincorporated organization or
other legal entity.

 

“Third Party” means
any Person other than a Party to this Agreement or its Affiliates.

 

SECTION
2: LICENSES AND RELEASE

 

2.1.         
License. Subject to the compliance by Licensee and its Affiliates with the terms and conditions of this Agreement,
and effective from the Effective Date, Licensor hereby grants to Licensee and its Affiliates, a non-exclusive, non-transferable,
non-assignable without the right to sublicense worldwide license under the Licensed Patents, to make, have made, use, import, export,
distribute, sell, offer for sale, develop and advertise Licensed Products. In addition, subject to the compliance by Licensee and
its Affiliates with the terms and conditions of this Agreement, and effective from the Effective Date, Licensor hereby grants to
the Licensee Third Parties a non-exclusive, non-transferable, non-assignable without the right to sublicense worldwide license
under the Licensed Patents, to make, have made, use, import, export, distribute, sell, offer for sale, develop and advertise Licensed
Products only. For the avoidance of doubt, the licenses granted in this Section ‎2.1 shall not extend to any product, device
or system of any Third Party other than Covered Third Party Products.

 

2.2.         
Release. Subject to the compliance by Licensee and its Affiliates with the terms and conditions of this Agreement,
Licensor hereby irrevocably releases and absolutely discharges Licensee, its Affiliates and Licensee Third Parties regarding the
Licensed Products prior to the Effective Date of this Agreement, including those Claims that are unknown, unanticipated or unsuspected
or that may hereafter arise as a result of the discovery of new and/or additional facts.

 

2.3.         
No Other Rights / No Exhaustion. No rights or covenants are granted under any Patents except as expressly provided
herein, whether by implication, estoppel or otherwise. No right to grant covenants, rights, sublicenses, or to become a foundry
for Third Parties is granted under this Agreement. The Parties agree that, except as explicitly set forth herein, the licenses
and release set forth in this Agreement expressly exclude any products, devices or systems of any Third Party. The Parties further
agree that, except as expressly provided herein, this Agreement does not limit in any manner Licensor’s rights to enjoin,
control or extract royalties with respect to products, devices or systems of any Third Party.

 

    	2

    	 

    

 

SECTION
3: MONETARY CONSIDERATION

 

3.1.         
Sales; Royalties. As further monetary consideration for the licenses and release granted by Licensor hereunder, in
addition to all of the other consideration provided for in this Agreement, Licensee shall pay Licensor royalties (“Royalties”)
equal to the Royalty Rate (as defined below) of Net Sales (as defined below) of all Licensed Products sold, licensed, leased or
otherwise disposed of (any of the foregoing, a “Sale”) by or on behalf of Licensee and its Affiliates.

 

For the purposes hereof:

 

“Royalty Rate”
shall mean six percent (6%).

 

“Net Sales” shall
mean the gross amount invoiced by Licensee or any of its Affiliates for Sales of Licensed Products, less, without duplication,
the sum of the following: (a) reasonable discounts, rebates, allowances or price adjustments actually granted; (b) sales, value
added, use, consumption, excise and/or similar taxes actually incurred; and (c) amounts refunded, credited or allowed on returns
for, or rejections of, Licensed Products.

 

3.2.         
Reporting; Future Payments. Licensee shall provide to Licensor within thirty (30) calendar days of the end of each
fiscal year (commencing upon the first year in which Net Sales reach $1M or more): (i) an executed certification from Licensee
attesting to the fact that during such year there were no Sales of Licensed Products by or on behalf of Licensee or its Affiliates;
or (ii) a royalty report in the form attached hereto as Exhibit B (the “Royalty Report”) stating,
inter alia, the type and total number of units of Licensed Products Sold through the end of the relevant fiscal quarter,
the Net Sales per unit of each unit, Net Sales generated therefrom, together with an executed certification from Licensee attesting
to the accuracy of the information contained therein, and (iii) shall make payment of the Royalties, no later than two (2) calendar
days following provision of the Royalty Report and certification by way of wire transfer to the account designated on Exhibit
B (or any other account designated by Licensor from time to time).

 

3.3.         
Books of Account; Inspection. Licensee shall keep accurate books of account containing all particulars that may be
necessary for the purpose of showing total Net Sales of the respective Licensed Products and the Royalties payable to Licensor
hereunder. Licensee shall make said books and the supporting data available for inspection by Licensor and/or its certified accountant
(Wirtschaftsprüfer) upon reasonable advance notice. Should inspection lead to the discovery of greater than five percent (5%)
discrepancy in reporting or payment to Licensor’s detriment, Licensee shall pay the reasonable fees and expenses of the inspection.
In any event, Licensee shall immediately pay to Licensor any and all amounts determined by any inspection to be owing to Licensor.

 

3.4.         
Taxes. Where VAT is chargeable on any payment to Licensor, Licensee shall be additionally liable for such VAT and
shall make the said payments plus VAT thereon. In addition, all payments to be made under this Agreement shall be made in cleared
funds, without any deduction or set-off and free and clear of and without deduction for or on account of any taxes, levies, imports,
duties, charges, fees and withholdings of any nature now or hereafter imposed by any governmental, fiscal or other authority save
as required by law (“Tax Deduction”). If a Party to this Agreement is compelled to make any such deduction,
it will pay to the entitled Party such additional amounts as are necessary to ensure receipt by the entitled Party of the full
amount which that Party would have received but for the deduction. If Licensee is required to make a Tax Deduction, Licensee shall
make that Tax Deduction and any payment required in connection with that Tax Deduction within the time allowed and in the minimum
amount required by law. The Parties shall co-operate in good faith to obtain the exemption certificate (Freistellungsbescheinigung)
or similar documents required by the tax authorities to allow the other Party to reduce any withholding taxes arising in connection
with the royalty payments. If no such exemption certificate can be obtained prior to the payment of the royalty payments, Licensee
shall make payment of such amount and Licensor hereby assigns any rights for a withholding tax refund towards the German Federal
Tax Office (Bundeszentralamt für Steuern) to Licensee.

 

    	3

    	 

    

 

3.5.         
Overdue Payments. Licensee and/or its Affiliates shall pay to Licensor interest on any payments due under this Agreement
that are at any time unpaid by Licensee and/or its Affiliates, at a rate equal to the higher of (i) two percent (2%) above the
prime rate prevailing at the Chase Manhattan Bank of New York or (ii) ten percent (10%), compounded annually, in effect in the
United States from the date when such payment is due and payable as provided herein to the date of payment.  The payment of
such interest shall not replace any of Licensee’s other rights under this Agreement resulting from Licensee's and/or its
Affiliates’ default by failure to pay any amounts due hereunder. If such interest rate exceeds the maximum legal rate in
the jurisdiction where a claim therefore is being asserted, the interest rate shall be reduced to such maximum legal rate.

 

Section
4: TERM and termination

 

4.1           Term. The term
of this Agreement shall commence upon the Effective Date and shall continue until the expiration of the last-to-expire Licensed
Patents.

 

4.2.         
Termination. If Licensee materially breaches this Agreement and does not cure such breach, to the extent capable
of being cured, within twenty-one (21) days after receipt of written notice (the “Breach Notice”) from Licensor,
then this Agreement may be terminated upon written notice to that effect (the “Termination Notice”) from Licensor
at any time after the expiration of twenty-one (21) days following receipt by Licensee of the Breach Notice.

 

4.3.         
Survival. In the event of termination pursuant to Section ‎4.2, the license and release granted to Licensee and
its Affiliates hereunder shall terminate as of the date that such termination takes effect and Licensor shall retain its rights
and remedies for such breach. The provisions of Sections 1, 2 (only as applicable to Licensor and its Affiliates), 4, 5, 6, 7,
8, and 9 will survive any termination of this Agreement.

 

4.4.         
Agreement Obligations Not Released.  Notwithstanding anything to the contrary herein, the Parties reserve all
rights and remedies, including damages and equitable relief (other than rescission, termination or reformation of this Agreement
to the extent not expressly provided for herein) for breach of this Agreement by the other Party and nothing herein releases either
Party from its respective obligations under this Agreement or prevents either Party from enforcing the terms and conditions of
this Agreement against the other Party.

 

SECTION 5: ASSIGNMENT

 

5.1           No Assignment by Licensee. Neither Licensee nor any Affiliate of Licensee may assign or transfer its rights under this
Agreement, in whole or in part without the prior written consent of Licensor, which will not be unreasonably withheld.

 

    	4

    	 

    

 

5.2.         
Permitted Assignment by Licensor. Licensor shall be permitted to sell, assign or otherwise transfer its rights under
this Agreement without Licensee’s consent to (i) an Affiliate; or (ii) a Third Party; provided that the license and release
of Licensor contained herein shall run with the rights being sold, assigned or transferred and shall be binding on any successors-in-interest,
transferees, or assigns thereof. Licensor and its Affiliates may sell, assign or otherwise transfer any Licensed Patent provided
that such sale, assignment, or transfer is subject to all of the terms and conditions of this Agreement.

 

5.3.         
Unpermitted Assignment Void. Any attempted transfer, license, assignment, or grant in contravention of this Section
shall be null and void. This Agreement shall be binding upon, inure to the benefit of and be enforceable by the Parties and their
permitted successors and assigns.

 

SEction
6: representations and warranties

 

6.1.         
Licensor Representations: Licensor represents and warrants with respect to the Licensed Patents, as of the Effective
Date that: (i) Licensor owns the Licensed Patents, and has the right to grant the license and release with respect to the Licensed
Patents of the full scope set forth herein; (ii) it has not assigned or otherwise transferred to any other Person any rights to
the Licensed Patents that would prevent Licensor from conveying the full scope of rights set forth herein; and (iii) the Person
executing this Agreement on behalf of Licensor has the full right and authority to enter into this Agreement on Licensor’s
behalf.

 

6.2.         
Licensee Representations: Licensee represents and warrants, on behalf of itself and its Affiliates, as of the Effective
Date that: (i) it has the right to grant the covenants of the full scope set forth herein; (ii) Licensee has the full right to
enter into this Agreement; (iii) no Licensed Products have been sold by or on behalf of Licensee or its Affiliates before the Effective
Date; and (iv) it will use its best commercial efforts to maximize sales of Licensed Products.

 

6.3.         
Exclusive Negotiations with Licensor. Licensee further represents and warrants, on behalf of itself and its Affiliates,
as of the Effective Date that it understands that it has exclusively negotiated and is contracting with Licensor, and acknowledges
it is not contracting (directly or indirectly, by any legal theory or otherwise) with any other Person or any Third Party and no
Person other than Licensor and Licensee are parties to this Agreement (directly or indirectly, by implication or under any legal
theory or otherwise).

 

6.4.         
No Warranties. Nothing contained in this Agreement shall be construed as: (i) a representation or warranty that the
Licensed Patents are valid or enforceable; (ii) an agreement by either Party to bring or prosecute actions or suits against Third
Parties for infringement, or conferring any right to the other Party to bring or prosecute actions or suits against Third Parties
for infringement; (iii) conferring any right to the other Party to use in advertising, publicity, or otherwise, any trademark,
trade name or names of either Party, or any contraction, abbreviation or simulation thereof without the prior written consent of
the other Party; or (iv conferring by implication, estoppel or otherwise, upon either Party, any right (including a license) under
other Patents except for the rights expressly granted hereunder.

 

SECTION 7: CONFIDENTIALITY

 

7.1.         
From and after the Effective Date, neither Party shall disclose the terms of this Agreement except: (i) with the prior written
consent of the other Party; (ii) to any court or other governmental body having jurisdiction and specifically requiring such disclosure;
(iii) in response to a valid subpoena or as otherwise may be required by law; (iv) for the purposes of disclosure in connection
with the Securities and Exchange Act of 1934, as amended, the Securities Act of 1933, as amended, and any other reports filed with
the Securities and Exchange Commission, or any other filings, reports or disclosures that may be required under applicable laws
or regulations; (v) to a Party’s accountants, legal counsel, tax advisors and other financial, legal and other professional
advisors, subject to obligations of confidentiality and/or privilege at least as stringent as those contained herein; (vi) as required
during the course of litigation and subject to protective order; provided however, that any production under a protective order
would be protected under an “Outside Attorneys Eyes Only” or higher confidentiality designation; (vii) with obligations
of confidentiality at least as stringent as those contained herein, to a counterparty in connection with a merger, acquisition,
sale of patents, financing or similar transaction; or (viii) for the Licensor, with obligations of confidentiality at least as
stringent as those contained herein, to potential licensees of the Licensed Patents.

 

    	5

    	 

    

 

SECTION 8: NOTICES

 

8.1.         
All notices required or permitted to be given hereunder shall be in writing and shall be delivered by hand, or if dispatched
by prepaid air courier with package tracing capabilities or by registered or certified airmail, postage prepaid, addressed as follows:

 

If to Licensor:

 

Magnus IP GmbH

c/o Managing Director

Barer Strasse 9

D-80333 München

Email: notice@marathonpg.com

 

Copy to:

Jennifer Watkins, Esq.

Email: Jennifer@marathonpg.com,

 

 

If to Licensee:

William Rosellini

77 Arrecife, Dorado, PR 00646

will@nexeonmed.com

 

Such notices shall
be deemed to have been served when received by addressee. Either Party may give written notice of a change of address and, after
notice of such change has been received, any notice or request shall thereafter be given to such Party as above provided at such
changed address.

 

SECTION 9: OTHER PROVISIONS 

 

9.1.         
Limitations on Publicity. Neither Party shall issue a press release or make any other public statement, regarding
the commercial terms of this Agreement without the prior written consent of the other Party, not to be unreasonably withheld.

 

9.2.         
Governing Law; Forum. This Agreement, its performance and interpretation shall be governed by the substantive law
of the State of Delaware, exclusive of its choice of law rules. Any dispute shall be resolved in an arbitration proceeding by one
(1) arbitrator selected pursuant to the rules of the International Chamber of Commerce, to be conducted by the International Chamber
of Commerce Court of Arbitration in accordance with the rules of such body as they then exist exclusively at the International
Chamber of Commerce location in Paris, France.

 

    	6

    	 

    

 

9.3.         
No Agency. Nothing in this Agreement is intended or shall be deemed to constitute a partnership, agency, employer-employee,
or joint venture relationship between the Parties. Neither Party shall incur any debts or make any commitments for the other. There
is no fiduciary duty or special relationship of any kind between the Parties to this Agreement. Each Party expressly disclaims
any reliance on any act, word, or deed of the other Party in entering into this Agreement.

 

9.4.         
No Further License; No Third Party Rights. Nothing contained in this Agreement shall be construed as conferring any
right to a license or to otherwise use any Patent, trademark, service name, service mark, trade dress, trade secret or other intellectual
property belonging to Licensor, except as expressly provided in this Agreement. Nothing in this Agreement is intended to confer
upon any Person, other than the Parties and their respective Affiliates, any rights, remedies, obligations or liabilities under
or by reason of this Agreement, except as expressly provided in this Agreement.

 

9.5.         
Sophisticated Parties Represented by Counsel. The Parties each acknowledge, accept, warrant and represent that (i)
they are sophisticated parties represented at all relevant times during the negotiation and execution of this Agreement by counsel
of their choice, and that they have executed this Agreement with the consent and on the advice of such independent legal counsel;
and (ii) they and their counsel have determined through independent investigation and robust, arm’s-length negotiation that
the terms of this Agreement shall exclusively embody and govern the subject matter of this Agreement.

 

9.6.         
Bankruptcy. With respect to the Licensed Patents that are US Patents, each Party irrevocably waives all arguments
and defenses arising under 11 U.S.C. 365(c)(1) or successor provisions to the effect that applicable law excuses the Party, other
than the debtor, from accepting performance from or rendering performance to a Person other than the debtor or debtor in possession
as a basis for opposing assumption of the Agreements by the other Party in a case under Chapter 11 of the Bankruptcy Code to the
extent that such consent is required under 11 U.S.C. § 365(c)(1) or any successor statute. Any change of control resulting
from any such bankruptcy proceeding shall remain subject to Section 5 above.

 

9.7.         
Severability. If any provision of this Agreement is held to be illegal or unenforceable, such provision shall be
limited or eliminated to the minimum extent necessary so that the remainder of this Agreement will continue in full force and effect
and be enforceable. The Parties agree to negotiate in good faith an enforceable substitute provision for any invalid or unenforceable
provision that most nearly achieves the intent of such provision.

 

9.8.         
Entire Agreement. The Parties acknowledge, accept, warrant and represent that (i) this is an enforceable agreement;
(ii) this Agreement embodies the entire and only understanding of each of them with respect to the subject matter of the Agreement,
and merges, supersedes and cancels all previous representations, warranties, assurances, communications, conditions, definitions,
understandings or any other statement, express, implied, or arising by operation of law, whether oral or written, whether by omission
or commission between and among them with respect to the subject matter of the Agreement; (iii) no oral explanation or oral information
by either Party hereto shall alter the meaning or interpretation of this Agreement; (iv) the terms and conditions of this Agreement
may be altered, modified, changed or amended only by a written agreement executed by duly authorized representatives of Licensor
and Licensee; (v) the language of this Agreement has been approved by counsel for each of them, and shall be construed as a whole
according to its fair meaning; and (vi) none of the them (nor their respective counsel) shall be deemed to be the draftsman of
this Agreement in any action which may hereafter arise with respect to the Agreement.

 

    	7

    	 

    

 

9.9.         
Modification; Waiver. No modification or amendment to this Agreement, nor any waiver of any rights, will be effective
unless assented to in writing by the Party to be charged, and the waiver of any breach or default will not constitute a waiver
of any other right hereunder or any subsequent breach or default.

 

9.10.      
Construction; Language. Any rule of construction to the effect that ambiguities are to be resolved against the drafting
party will not be applied in the construction or interpretation of this Agreement. As used in this Agreement, the words “include”
and “including” and variations thereof, will not be deemed to be terms of limitation, but rather will be deemed to
be followed by the words “without limitation.” The headings in this Agreement will not be referred to in connection
with the construction or interpretation of this Agreement. This Agreement is in the English language only, which language shall
be controlling in all respects, and all notices under this Agreement shall be in the English language.

 

9.11.      
Counterparts. This Agreement may be executed in counterparts or duplicate originals, both of which shall be regarded
as one and the same instrument, and which shall be the official and governing version in the interpretation of this Agreement.
This Agreement may be executed by facsimile signatures or other electronic means and such signatures shall be deemed to bind each
Party as if they were original signatures.

 

[Signature Page
Follows]

 

    	8

    	 

    

 

IN
WITNESS WHEREOF, the Parties hereto have caused this Agreement to be signed below by their respective duly authorized officers.

 

	Magnus
                                         IP GmbH
	 	
	 	 	 	 
	 	 	 	 
	By:		 	
	 	Name:

                                Title:
	 	

 

 

	 	 	 
	 	 	 
	Will
    Rosellini	 	
	 	 	 	 
	 	 	 	 
	By:	/s/
    Will Rosellini	 	
	 	Name:
                                Will Rosellini

                                Title: 
	 	

 

 

 

 

 

    	9

    	 

    

 

EXHIBIT A

LICENSED
PATENTS

 

Attached.

 

    	1

    	 

    

 

 

 

    	2

    	 

    

 

 

 

    	3

    	 

    

 

 

 

 

 

 

 

 

 

 

 

    	4

    	 

    

 

EXHIBIT B

ROYALTY
REPORT

 

Will Rosellini,
a Puerto Rican resident, residing at 77 Arrecife, Dorado, PR 00646, represents and warrants to Magnus IP GmbH that the following
is a true, accurate and complete accounting of units of the Licensed Products Sold during the fiscal year identified below. (Capitalized
terms not otherwise defined herein shall have the meanings ascribed thereto in that certain License Agreement, between Magnus
IP GmbH and Will Rosellini, dated September 29, 2016).

 

Fiscal
Year: __________ - ___________.

 

	Type
    of Licensed Product	Number
    of Licensed Product Sold	Net
    Sales per Unit 	Net
    Sales Amount	Royalty
    Percentage (%)	Royalty
    Payment Due
	 	 	 	 	 	 
	 	 	 	 	 	 
	 	 	 	 	 	 
	 	 	 	 	 	 
	Total:	 	 	 	 	 

 

    	1

    	 

    

 

 

I HEREBY CERTIFY
THAT THE ABOVE REPORT IS TRUE, ACCURATE AND COMPLETE.

 

Will Rosellini

 

Signed:      _________________________________________

Date:          ________________

 

Send report to:

 

Magnus IP GmbH

c/o Managing Director

Barer Strasse 9

D-80333 München

Email: notice@marathonpg.com

 

 

Wire Transfer Information for
any Royalty Payments due:

 

HypoVereinsbank/UniCredit Bank AG 

BIC: HYVEDEMMXXX 

IBAN: DE66 7002 0270 0015 3772 36

 

    	2Exhibit

Exhibit 4.1

EXECUTION VERSION

                                                        

$35,000,000
11.000% Senior Secured Bridge Note due 2019
HC2 Holdings 2, Inc.
promises to pay to Jefferies LLC (the “Purchaser”), the holder of this 11.000% Senior Secured Bridge Note due 2019 (the “Bridge Note”), the principal sum of THIRTY FIVE MILLION DOLLARS on December 1, 2019.
Interest Payment Dates:  December 1 and June 1
Record Dates:  November 15 and May 15
Dated:  December 16, 2016

                                                        

1

HC2 Holdings 2, Inc.,
As Bridge Note Issuer

By:    /s/ Michael J. Sena                    
Name:  Michael J. Sena
Title:     Chief Financial Officer

2

11.000% Senior Secured Bridge Note due 2019
INTEREST.  HC2 Holdings 2, Inc., a Delaware corporation (the “Bridge Note Issuer”), promises to pay or cause to be paid interest on the principal amount of this Bridge Note at 11.000% per annum until maturity.  The Bridge Note Issuer will pay interest, if any, semi-annually in arrears on December 1 and June 1 of each year, or if any such day is not a Business Day, on the next succeeding Business Day (each, an “Interest Payment Date”).  Interest on this Bridge Note will accrue from the date of issuance and the first Interest Payment Date shall be June 1, 2017.  The Bridge Note Issuer will pay interest (including post-petition interest in any proceeding under any Bankruptcy Law (as defined in the indenture, dated as of November 20, 2014 (the “Existing Indenture”), among HC2 Holdings, Inc., a Delaware corporation (the “Company”), the guarantors party thereto and U.S. Bank National Association, as trustee (in such capacity, the “Trustee”) and as collateral trustee (in such capacity, the “Collateral Trustee”) on overdue principal at a rate that is 1% higher than the then applicable interest rate on this Bridge Note to the extent lawful; it will pay interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue installments of interest, if any (without regard to any applicable grace period), at the same rate to the extent lawful.
Interest will be computed on the basis of a 360-day year comprised of twelve 30-day months.
METHOD OF PAYMENT.  The Bridge Note Issuer will pay interest on this Bridge Note (except defaulted interest), if any, to the Purchaser at the close of business on the November 15 or May 15 next preceding the Interest Payment Date, even if such Bridge Note is canceled after such record date and on or before such Interest Payment Date, except with respect to defaulted interest.   The Notes will be payable as to principal, premium, if any, and interest, if any, by wire transfer of immediately available funds to the Purchaser pursuant to wire transfer instructions separately provided to the Bridge Note Issuer.  Such payment will be in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debts.
COVENANTS.  Section 3.09 and Article 4 (other than Section 4.02 thereof) of the Existing Indenture (together with the defined terms used therein, in each case, as in effect on the date hereof) is incorporated by reference herein as if originally appearing herein; provided, however, that to the extent that any provision of any such Section or Article (or definition used therein) is included in Schedule I attached hereto, such provision (or definition) shall be deemed to have been incorporated herein as if originally appearing herein in the form set forth in such Schedule.
MERGER, CONSOLIDATION OR SALE OF ASSETS.  Neither the Company nor the Bridge Note Issuer shall, directly or indirectly: (i) (A) consolidate or merge with or into another Person; (B) sell, convey, transfer or otherwise dispose of all or substantially all of its assets as an entirety or substantially an entirety, in one transaction or a series of related transactions, to any Person; or (C) permit any Person to merge with or into either the Company or the Bridge Note Issuer, unless the Company or (except with respect to a transaction involving the Company) the Bridge Note Issuer, as the case may be, is the surviving corporation or (ii) lease all or substantially all of its assets, whether in one transaction or a series of transactions, to one or more other Persons; provided, however, that the foregoing subclauses (i) and (ii) shall not apply to (1) any transfer of assets among the Company, the Bridge Note Issuer and a Guarantor, (2) any transfer of assets among Guarantors and the Bridge Note Issuer or (iii) any transfer of assets by a Subsidiary that is not a Guarantor to (x) another Subsidiary that is not a Guarantor or the Bridge Note Issuer or (y) the Company, the Bridge Note Issuer or any Subsidiary Guarantor.
DEFAULTS AND REMEDIES.  Section 6.01 of the Existing Indenture (together with the defined terms used therein, in each case, as in effect on the date hereof) is incorporated by reference herein as if originally appearing herein; provided, however, that to the extent that any provision of such Section (or definition used therein) is included in Schedule II attached hereto, such provision (or definition) shall be deemed to have been incorporated herein as if originally appearing herein in the form set forth in such Schedule. 

3

If an Event of Default, other than a default under Section 6.01(h) or (i) of the Existing Indenture (as incorporated by reference in the section entitled “Covenants” hereof) with respect to the Company or the Bridge Note Issuer, occurs and is continuing under this Agreement, the Purchaser, by written notice to the Company and the Bridge Note Issuer, may declare the principal of and accrued interest on the Bridge Note to be immediately due and payable. Upon a declaration of acceleration, such principal and interest will become immediately due and payable. If an Event of Default under Section 6.01(h) or (i) of the Existing Indenture (as incorporated by reference in the section entitled “Covenants” hereof) occurs with respect to the Company or the Bridge Note Issuer, the principal of and accrued interest on the Bridge Note then outstanding will become immediately due and payable without any declaration or other act on the part of the Purchaser.
In the event of a declaration of acceleration of the Bridge Note because an Event of Default under Section 6.01(f) of the Existing Indenture (as incorporated by reference in the section entitled “Covenants” hereof) has occurred and is continuing, the declaration of acceleration of the Bridge Note shall be automatically annulled if the event of default or payment default triggering such Section 6.01(f) shall be remedied or cured, or waived by the holders of the Debt, or the Debt that gave rise to such Event of Default shall have been discharged in full, within 30 days after the declaration of acceleration with respect thereto and if (1) the annulment of the acceleration of the Bridge Note would not conflict with any judgment or decree of a court of competent jurisdiction and (2) all existing Events of Default, except nonpayment of principal, premium or interest on the Bridge Note that became due solely because of the acceleration of the Bridge Note, have been cured or waived.
If an Event of Default occurs and is continuing, the Purchaser may pursue any available remedy to collect the payment of principal of, premium on, if any, or interest, if any, on the Bridge Note or to enforce the performance of any provision of the Bridge Note or this Agreement.
A delay or omission by the Purchaser in exercising any right or remedy accruing upon an Event of Default shall not impair the right or remedy or constitute a waiver of or acquiescence in the Event of Default.  All remedies are cumulative to the extent permitted by law.
COLLATERAL.  Article 10 of the Existing Indenture (other than Sections 10.04 through 10.06 thereof) (together with the defined terms used therein, in each case, as in effect on the date hereof) is incorporated by reference herein as if originally appearing herein; provided, however, that to the extent that any provision of such Article (or definition used therein) is included in Schedule III attached  hereto, such provision (or definition) shall be deemed to have been incorporated herein as if originally appearing herein in the form set forth in such Schedule.
BRIDGE NOTE GUARANTEES. Article 11 of the Existing Indenture (together with the defined terms used therein, in each case, as in effect on the date hereof) is incorporated by reference herein as if originally appearing herein; provided, however, that to the extent that any provision of such Article (or definition used therein) is included in Schedule IV attached hereto, such provision (or definition) shall be deemed to have been incorporated herein as if originally appearing herein in the form set forth in such Schedule.
OPTIONAL REDEMPTION. The Bridge Note Issuer may on any one or more occasions redeem all or a part of this Bridge Note, upon not less than 30 nor more than 60 days’ notice, at 100.000% of the principal amount thereof, plus accrued and unpaid interest, if any, on this Bridge Note, to the applicable date of redemption, subject to the rights of the Purchaser on the relevant record date to receive interest on the relevant Interest Payment Date. Unless the Bridge Note Issuer defaults in the payment of the redemption price, interest will cease to accrue on this Bridge Note or portions thereof called for redemption on the applicable redemption date.

4

REPURCHASE AT THE OPTION OF PURCHASER.
(A)Upon the occurrence of a Change of Control (as defined in the Existing Indenture), the Bridge Note Issuer will be required to make an offer (a “Change of Control Offer”) to the Purchaser to repurchase all or any part of this Bridge Note at a purchase price in cash equal to 101% of the aggregate principal amount of this Bridge Note repurchased, plus accrued and unpaid interest, if any, on this Bridge Note to the date of purchase, subject to the rights of the Purchaser on the relevant record date to receive interest due on the relevant interest payment date (the “Change of Control Payment”).  Within ten days following any Change of Control, the Bridge Note Issuer will mail a notice to Purchaser setting forth the procedures governing the Change of Control Offer. A Change of Control Offer may be made in advance of a Change of Control, conditional upon such Change of Control, if a definitive agreement is in place for the Change of Control at the time of making of the Change of Control Offer. 
(B)If the Company or a Restricted Subsidiary of the Company consummates any Asset Sales (as defined in the Existing Indenture), within five days of each date on which the aggregate amount of Excess Proceeds exceeds $20.0 million, the Bridge Note Issuer will make an Asset Sale Offer to Purchaser and all holders of other Indebtedness that is pari passu with this Bridge Note containing provisions similar to those set forth in the Existing Indenture with respect to offers to purchase, prepay or redeem with the proceeds of sales of assets in accordance with the Existing Indenture to purchase, prepay or redeem the maximum principal amount of the Bridge Note and such other pari passu Indebtedness (plus all accrued interest on the Indebtedness and the amount of all fees and expenses, including premiums, incurred in connection therewith) that may be purchased, prepaid or redeemed out of the Excess Proceeds.  The offer price in any Asset Sale Offer will be equal to 100% of the principal amount, plus accrued and unpaid interest, if any, to the date of purchase, prepayment or redemption, subject to the rights of the Purchaser on the relevant record date to receive interest due on the relevant interest payment date, and will be payable in cash.  If any Excess Proceeds remain after consummation of an Asset Sale Offer, the Company may use those Excess Proceeds for any purpose not otherwise prohibited by the Existing Indenture or this Bridge Note.  Upon completion of each Asset Sale Offer, the amount of Excess Proceeds will be reset at zero.  If the Purchaser is subject to an offer to purchase, it will receive an Asset Sale Offer from the Bridge Note Issuer prior to any related purchase date and may elect to have such Bridge Note purchased by completing the form entitled “Option of Purchaser to Elect Purchase” attached to this Bridge Note.
NOTICE OF REDEMPTION.  At least 30 days but not more than 60 days before a redemption date, the Bridge Note Issuer will mail or cause to be mailed, by first class mail, a notice of redemption to the Purchaser at its registered address.  Any such redemption may, at the Bridge Note Issuer’s discretion, be subject to one or more conditions precedent, including any related Equity Offering or a Change of Control.  In addition, if such redemption is subject to the satisfaction of one or more conditions precedent, the related notice shall describe each such condition, and if applicable, shall state that, in the Bridge Note Issuer’s discretion, the date of redemption may be delayed until such time as any or all such conditions shall be satisfied or waived (provided that in no event shall such date of redemption be delayed to a date later than 60 days after the date on which such notice was mailed), or such redemption or purchase may not occur and such notice may be rescinded in the event that any or all such conditions shall not have been satisfied or waived by the date of redemption, or by the date of redemption as so delayed.
EXCHANGE.  The Company and the Bridge Note Issuer will exchange this Bridge Note for an equal principal amount of the Company’s 11.000% Senior Secured Notes due 2019 to be issued pursuant to the Existing Indenture at the time of the issuance of such Bridge Notes in accordance with the terms of a note purchase and exchange agreement, dated the date hereof, among the Company, the Bridge Note Issuer, the guarantors party thereto and the purchaser party thereto.
NO RECOURSE AGAINST OTHERS.  No director, officer, employee, incorporator or stockholder of the Bridge Note Issuer, the Company or any Guarantor, as such, will have any liability for any obligations of the Bridge Note Issuer, the Company or the Guarantors under the Bridge Note, the Purchase and Exchange Agreement, the Existing Indenture, the Bridge Note Guarantees, the Security Documents or for any claim 

5

based on, in respect of, or by reason of, such obligations or their creation.  The Purchaser, by accepting this Bridge Note waives and releases all such liability.  The waiver and release are part of the consideration for issuance of the Bridge Note.  The waiver may not be effective to waive liabilities under the federal securities laws.
AMENDMENT AND WAIVER.  This Bridge Note may be amended or supplemented with the consent of the Purchaser, and any existing Default or Event of Default or compliance with any provision of this Bridge Note may be waived with the consent of the Purchaser. 
NOTICES.  Any notice or communication by the Company, the Bridge Note Issuer, any Guarantor or the Purchaser to the others is duly given if in writing and delivered in Person or by first class mail (registered or certified, return receipt requested), facsimile transmission or overnight air courier guaranteeing next day delivery, to the others’ address:
If to the Company, the Bridge Note Issuer and/or any Guarantor:
HC2 Holdings, Inc.
Attention: Paul Robinson
c/o HC2 Holdings,
450 Park Avenue, 30th Floor
New York, NY 10022

If to the Purchaser:

Jefferies LLC
520 Madison Avenue
New York, NY 10022

The Company, the Bridge Note Issuer, any Guarantor or the Purchaser, by notice to the others, may designate additional or different addresses for subsequent notices or communications.
All notices and communications will be deemed to have been duly given: at the time delivered by hand, if personally delivered; five Business Days after being deposited in the mail, postage prepaid, if mailed; when receipt acknowledged, if transmitted by facsimile; and the next Business Day after timely delivery to the courier, if sent by overnight air courier guaranteeing next day delivery.
If a notice or communication is provided in the manner set forth above within the time prescribed, it is duly given, whether or not the addressee receives it.
SUCCESSORS.  All agreements of the Company and the Bridge Note Issuer in this Bridge Note will bind their respective successors.  All agreements of each Guarantor in this Bridge Note will bind its successors, except as otherwise provided in Section 11.05 of the Existing Indenture (as incorporated by reference in the section entitled “Bridge Note Guarantees” hereof).
SEVERABILITY.  In case any provision in this Bridge Note is invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions will not in any way be affected or impaired thereby.
HEADINGS.  The headings of sections of this Bridge Note (including in any Schedules hereto) have been inserted for convenience of reference only, are not to be considered a part of this Bridge Note and will in no way modify or restrict any of the terms or provisions hereof.

6

GOVERNING LAW.  THE INTERNAL LAW OF THE STATE OF NEW YORK WILL GOVERN AND BE USED TO CONSTRUE THE PURCHASE AND EXCHANGE AGREEMENT, THIS BRIDGE NOTE AND THE BRIDGE NOTE GUARANTEES WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY.

7

Option of the Purchaser to Elect Purchase

If you want to elect to have this Bridge Note purchased by the Bridge Note Issuer pursuant to the Repurchase at the Option of the Purchaser provisions set forth in the Bridge Note, check the appropriate box below:
Change of Control Offer     Asset Sale Offer
If you want to elect to have only part of the Bridge Note purchased by the Bridge Note Issuer pursuant to the Repurchase at the Option of the Purchaser, state the amount you elect to have purchased:
$_______________

Date:  _______________
Your Signature:    ___________________________________________
(Sign exactly as your name appears on the face of this
Bridge Note)
Tax Identification No.:    ____________________________________

Signature Guarantee*:  _________________________

*    Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee).

8

NOTATION OF GUARANTEE
For value received, the Company and each other Guarantor (which term includes any successor Person under the Bridge Note) has, jointly and severally, unconditionally guaranteed, to the extent set forth in Bridge Note and subject to the provisions thereof, (a) the due and punctual payment of the principal of, premium on, if any, and interest, if any, on, the Bridge Note, whether at maturity, by acceleration, redemption or otherwise, the due and punctual payment of interest on overdue principal of, premium on, if any, and interest, if any, on, the Bridge Note, if any, if lawful, and the due and punctual performance of all other obligations of the Bridge Note Issuer to the Purchaser all in accordance with the terms of the Bridge Note and (b) in case of any extension of time of payment or renewal of any Bridge Note or any of such other obligations, that the same will be promptly paid in full when due or performed in accordance with the terms of the extension or renewal, whether at stated maturity, by acceleration or otherwise.  The obligations of the Company and the other Guarantors to the Purchaser pursuant to the Note Guarantee and the Bridge Note are set forth in the section entitled “Bridge Note Guarantees” of the Bridge Note, which section, together with the section entitled “Governing Law,” are incorporated by reference herein.
Capitalized terms used but not defined herein have the meanings given to them in the Bridge Note.
[Name of Guarantors] 

By:                                                                            
Name:                                                                           
Title:                                                                           

1

SCHEDULE I
MODIFICATIONS TO COVENANTS
Modified Terms:
	
		
	Term
	Definition for purposes of the section entitled “Covenants” in the Bridge Note, except to the extent otherwise provided under “Modified Provisions” below

	Indenture
	Bridge Note

	Issue Date
	November 20, 2014

	Net Cash Proceeds
	Net Proceeds (as defined in the Existing Indenture (as in effect on the date of the Bridge Note))

	Note Guarantee
	The guaranty of the Bridge Note by the Company or a Guarantor pursuant to the section entitled “Bridge Note Guarantees” of the Bridge Note.

	Notes
	Bridge Note

	Subsidiary Guarantors
	The Bridge Note Issuer and each other Subsidiary of the Company that is a party to the Bridge Note as a Guarantor or that executes a joinder to the Bridge Note providing for the guaranty of the payment of the Bridge Note, or any successor obligor under its Note Guarantee pursuant to Section 11.04 of the Existing Indenture (as incorporated by reference in the section entitled “Bridge Note Guarantees” of the Bridge Note), in each case unless and until such Guarantor is released from its Note Guarantee pursuant to the Section 11.05 of the Existing Indenture (as incorporated by reference in the section entitled “Bridge Note Guarantees” of the Bridge Note).

	Trustee
	The Purchaser

	 
	 

	References to Sections and Articles
	Unless the context otherwise requires, such Section or Article as incorporated by reference in the Bridge Note

Modified Provisions:
		
	1.
	Clauses (2) and (3) of the definition of the term “Permitted Liens” are amended and restated in their respective entireties to read as follow:

“(2) Liens on the Collateral to secure Obligations in respect of the Bridge Notes (excluding any Additional Notes) and the Note Guarantees;
(3) Liens on the Collateral that rank pari passu with or junior to the Liens securing the Obligations in respect of the Bridge Notes or the Note Guarantees, as the case may be, and that secure Obligations in respect of Debt (including any Additional Notes) Incurred pursuant to clause (1), (4)(A) or (13) of the definition of Permitted Debt;”
		
	2.
	 Clauses (6) and (7) of the fourth paragraph of Section 3.09 are amended and restated in their respective entireties to read as follow:

“(6) that if the Purchaser Holders electsing to have all or a portion of the Bridge Notes purchased pursuant to any Asset Sale Offer, it will be required to surrender the Bridge Note, with the form entitled “Option of Purchaser to Elect Purchase” attached to the Bridge Notes completed, or transfer by book-entry transfer, to the Company, a Depositary, if appointed by the Company, or a Paying Agent at the address specified in the notice at least three days before the Purchase Date;

Schedule I-1

(7) that Holders the Purchaser will be entitled to withdraw their its election if the Company, the Depositary or the Paying Agent, as the case may be, receives, not later than the expiration of the Offer Period, a telegram, telex, facsimile transmission or letter setting forth the name of the Holder Purchaser, the principal amount of the Bridge Note the Holder Purchaser delivered for purchase and a statement that such Holder the Purchaser is withdrawing his its election to have such the Bridge Note purchased;”.
		
	3.
	The last two paragraphs of Section 3.09 are amended and restated in their respective entireties to read as follow:

“On or before the Purchase Date, the Company will, to the extent lawful, accept for payment, on a pro rata basis to the extent necessary, the Offer Amount of Bridge Notes or portions thereof tendered pursuant to the Asset Sale Offer, or if less than the Offer Amount has been tendered, all the Bridge Notes tendered, and will deliver or cause to be delivered to the Trustee the Notes properly accepted together with an Officers’ Certificate stating that Notes or portions thereof were accepted for payment by the Company in accordance with the terms of this Section 3.09. The Company, the Depositary or the Paying Agent, as the case may be, will promptly (but in any case not later than five days after the Purchase Date) mail or deliver to each tendering Holder the Purchaser an amount equal to the purchase price of the Bridge Notes tendered by such Holder the Purchaser and accepted by the Company for purchase, and the Company Bridge Note Issuer will promptly issue a new Bridge Note, and the Trustee, upon written request from the Company, will authenticate and mail or deliver (or cause to be transferred by book entry) such new Bridge Note to such Holder the Purchaser, in a principal amount equal to any unpurchased portion of the Bridge Note surrendered. Any Note not so accepted shall be promptly mailed or delivered by the Company to the Holder thereof. The Company will publicly announce the results of the Asset Sale Offer on the Purchase Date.
Other than as specifically provided in this Section 3.09, any purchase pursuant to this Section 3.09 shall be made pursuant to the provisions of Sections 3.01 through 3.06 hereofIf the Bridge Note or any portion thereof is repurchased by the Company as contemplated under this Section 3.09, the Company shall contribute the Bridge Note or portion thereof that is so repurchased to the Bridge Note Issuer for retirement and cancellation and shall cause the Bridge Note Issuer to so retire cancel the same.”
		
	4.
	Section 4.01 is amended and restated in its entirety to read as follow:

“Section 4.01 Payment of Bridge Notes.  The Company Bridge Note Issuer will pay or cause to be paid the principal of, premium on, if any, and interest, if any, on, the Bridge Notes on the dates and in the manner provided in the Bridge Notes.  Principal, premium, if any, and interest, if any, will be considered paid on the date due if the Purchaser is in receipt no later than Paying Agent, if other than the Company or a Subsidiary thereof, holds as of 10:00 a.m. Eastern Time on the due date money paid deposited by the Company Bridge Note Issuer in immediately available funds and designated for and sufficient to pay all principal, premium, if any, and interest, if any, then due.
The Company Bridge Note Issuer will pay interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue principal at a rate that is 1% higher than the then applicable interest rate on the Bridge Notes to the extent lawful; it will pay interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue installments of interest, if any (without regard to any applicable grace period), at the same rate to the extent lawful.”.
		
	5.
	Section 4.05(f) is amended to delete the words “Article 6” therefrom and insert the words “Section 8” in lieu thereof.

		
	6.
	Section 4.06(b) is amended to delete the words “Article 4 or Article 5” therefrom and insert the words “Section 7(n) or (o)” in lieu thereof.

Schedule I-2

		
	7.
	Sections 4.09(b)(8) and (9) are amended and restated in their respective entireties to read as follow:

“(8)    Restricted Payments not otherwise permitted hereby in an aggregate amount not to exceed $1.0 million since November 20, 2014;
(9)    (a) repurchases of Equity Interests deemed to occur upon the exercise of stock options or warrants if the Equity Interests represent all or a portion of the exercise price thereof (or related withholding taxes) and (b) Restricted Payments by the Company or any Restricted Subsidiary to allow the payment of cash in lieu of the issuance of fractional shares upon the exercise of options or warrants or upon the conversion or exchange of Equity Interests of the Company or any Restricted Subsidiary in an aggregate amount under this clause (b) not to exceed $1.0 million since November 20, 2014;”.
		
	8.
	Section 4.10(b)(1) is amended and restated in its entirety to read as follow:

“(1)    existing on (A) the Issue Date November 20, 2014 in this Indenture or any other agreements in effect on the Issue Date November 20, 2014 and (B) the date hereof in this Bridge Note, and any extensions, renewals, replacements or refinancings of any of the foregoing; provided that the encumbrances and restrictions in the extension, renewal, replacement or refinancing are, taken as a whole, no less favorable in any material respect to the noteholders Purchaser than the encumbrances or restrictions being extended, renewed, replaced or refinanced;”.
		
	9.
	Section 4.11(b)(4) is amended and restated in its entirety to read as follow:

“(4)    Debt of (A) the Company pursuant to the Existing Notes in an aggregate principal amount not exceeding $307 million at any one time outstanding (other than Additional Notes) and Debt of the Bridge Note Issuer and any Subsidiary Guarantor pursuant to a Note Guarantee thereof (including Additional Notes) and (B) the Bridge Note Issuer pursuant to the Bridge Note and Debt of the Guarantors pursuant to the Note Guarantees;”.
		
	10.
	Section 4.13(c)(5) is amended and restated in its entirety to read as follow:

“(5)    transactions pursuant to any contract or agreement in effect on November 20, 2014 the Issue Date, as amended, modified or replaced from time to time so long as the terms of the amended, modified or new agreements, taken as a whole, are no less favorable to the Company and any applicable Restricted Subsidiary than those in effect on November 20, 2014 the date of this Indenture;”.
		
	11.
	Section 4.15 is amended to delete the words “Article 5 hereof” therefrom and insert the words “Sections 7(o) hereof and Section 11.04 of the Existing Indenture (as incorporated by reference in the section entitled “Bridge Note Guarantees” of the Bridge Note)” in lieu thereof.

		
	12.
	Sections 4.16(b), (c), (d) and (f) are amended and restated in their respective entireties to read as follow:

“(b)    On or before the Change of Control Payment Date, the Company will, to the extent lawful:
(1)    accept for payment all the Bridge Notes or portions thereof properly tendered pursuant to the Change of Control Offer; and
(2)    deposit with the paying agent promptly mail or wire transfer to the Purchaser an amount equal to the Change of Control Payment in respect of all the Bridge Notes or portions thereof properly tendered; and
(3)    deliver or cause to be delivered to the Trustee the Notes so accepted together with an Officer’s Certificate stating the aggregate principal amount of Notes or portions thereof being purchased by the Company.

Schedule I-3

(c)    The Bridge Note Issuer paying agent will promptly mail or wire transfer to each Holder of Notes properly tendered the Change of Control Payment for such Notes, and the Trustee will promptly authenticate issue and mail (or cause to be transferred by book entry) to each Holder the Purchaser a new Bridge Nnote equal in principal amount to any unpurchased portion of the Bridge Notes surrendered, if any; provided that such new Bridge Nnote will be in a principal amount of $2,000 or a higher integral multiple of $1,000.
(d)    The Company will not be required to make a Change of Control Offer upon a Change of Control if (1) a third party makes the Change of Control Offer in the manner, at the times and otherwise in compliance with the requirements set forth in this Indenture applicable to a Change of Control Offer made by the Company and purchases all the Bridge Notes if it has been validly tendered and not withdrawn under such Change of Control Offer or (2) notice of redemption has been given with respect to all the Notes pursuant to the Bridge Notehereof, unless and until there is a default in payment of the applicable redemption price.
(f)    If the Bridge Notes or any portion thereof is repurchased by the Company pursuant to a Change of Control Offer, the Company will contributed the Bridge Note or such portion to the Bridge Note Issuer for retirement and cancellation and shall cause the Bridge Note Issuer to so retire and cancel the same have the status of notes issued but not outstanding or will be retired and cancelled at the option of the Company.  Notes purchased by a third party pursuant to this Section 4.16 will have the status of Notes issued and outstanding.”.
		
	13.
	Section 4.18 is amended and restated in its entirety to read as follow:

“Section 4.18    Additional Note Guarantees.
If any Domestic Subsidiary of the Company Guarantees any Debt of the Company, the Bridge Note Issuer or a Subsidiary Guarantor after the date of this Bridge Note, then that Domestic Subsidiary will within 15 Bbusiness Ddays of the date on which it Guarantees any Debt of the Company, the Bridge Note Issuer or a Subsidiary Guarantor (i) execute and deliver to the Trustee Purchaser a supplemental indenture Notation of Guarantee substantially in the form attached to this Indenture Bridge Note pursuant to which such Domestic Subsidiary will guarantee the Bridge Notes, and (ii) execute and deliver to the Collateral Trustee joinder agreements or other similar agreements with respect the applicable Security Documents. Each Note Guarantee shall be automatically released as described under Section 11.05 of the Existing Indenture (as incorporated by reference in the section entitled “Bridge Note Guarantees” of the Bridge Note).  The form of such supplemental indenture Note Guarantee joinder is attached as Exhibit F A hereto.”.
		
	14.
	The first sentence of Section 4.19 is amended to insert the words “(other than the Bridge Note Issuer)” immediately following the words “any Restricted Subsidiary” and immediately preceding the words “to be an Unrestricted Subsidiary”, in each case, therein.

		
	15.
	Section 4.23(a) is amended and restated in its entirety to read as follow:

“(a)    After the date of the Bridge NoteIssue Date, following the first day:  (i) the Existing Notes have Investment Grade Ratings from both Rating Agencies; and (ii) no Default has occurred and is continuing under this Bridge NoteIndenture; the Company and its Restricted Subsidiaries shall not be subject to Sections 4.03, 4.09, 4.10, 4.11, 4.12, and 4.13, and 5.01(a)(3) of the Existing Indenture (as incorporated by reference in the section entitled “Covenants” of the Bridge Note) (collectively, the “Suspended Covenants”).”

Schedule I-4

SCHEDULE II
MODIFICATIONS TO EVENTS OF DEFAULTS
Modified Terms:
	
		
	Term
	Definition for purposes of “Defaults and Remedies” of the Bridge Note, except to the extent otherwise provided under “Modified Provisions” below

	Indenture
	Bridge Note

	Note Guarantee
	The guaranty of the Bridge Notes by a Guarantor or the Company pursuant to the section entitled “Bridge Note Guarantees” of the Bridge Note t.

	Significant Subsidiaries
	The Bridge Note Issuer and each other Subsidiary, or group of Subsidiaries, of the Company that would, taken together, be a “significant subsidiary” as defined in Article 1, Rule 1-02 (w)(1) or (2) of Regulation S-X promulgated under the Securities Act, as such regulation is in effect on the date of the Bridge Note, substituting 20 percent for 10 percent in the tests used therein to determine significant subsidiary.

	Subsidiary Guarantors
	Each Subsidiary of the Company that is a party to the Bridge Note as a Guarantor or that executes a joinder to the Bridge Note providing for the guaranty of the payment of the Bridge Notes, or any successor obligor under its Note Guarantee pursuant to Section 11.04 of the Existing Indenture (as incorporated by reference in the section entitled “Bridge Note Guarantees” of the Bridge Note), in each case unless and until such Guarantor is released from its Note Guarantee pursuant to the Section 11.05 of the Existing Indenture (as incorporated by reference in the section entitled “Bridge Note Guarantees” of the Bridge Note).

	Trustee
	The Purchaser

	 
	 

	References to Sections and Articles
	Unless the context otherwise requires, such Section or Article as incorporated by reference in the Bridge Note

Modified Provisions:
		
	1.
	Sections 6.01(a), (b), (c), (e), (j) and (k) are amended and restated in their respective entireties to read as follow:

“(a)    the Company Bridge Note Issuer defaults in the payment of the principal of any Bridge Nnote when the same becomes due and payable at maturity, upon acceleration or redemption, or otherwise (other than pursuant to an Offer to Purchase);
(b)    the Company Bridge Note Issuer defaults in the payment of interest on any Bridge Nnote when the same becomes due and payable, and the default continues for a period of 30 days;
(c)    failure by the Company to comply with the provisions of Sections 4.12 or 4.16 hereof the Existing Indenture (as incorporated by reference in the section entitled “Covenants” of the Bridge Note) or failure by the Company or any of its Restricted Subsidiaries to comply with the provisions of Section 5.01 7(o) hereof or Section 11.04 of the Existing Indenture (as incorporated by reference in the section entitled “Bridge Note Guarantees” of the Bridge Note);
(e)    the Company defaults in the performance of or breaches any other covenant or agreement of the Company in this Indenture, the Pledge Agreement or under the Bridge Notes and the default or breach continues for a period of 60 consecutive days after written notice to the Company by the Purchaser Trustee or to the Company and the Trustee by the Holders of 25% or more in aggregate principal amount of the Notes);

Schedule II-1

(j)    any Note Guarantee of the Company or a Significant Subsidiary ceases to be in full force and effect, other than in accordance the terms of this Indenture Bridge Note, or the Company or a Guarantor that is a Significant Subsidiary denies or disaffirms its obligations under its Note Guarantee; or
(k)    (a) the Liens created by the Security Documents shall at any time not constitute a valid and perfected Lien on any portion of the Collateral (with a fair market value in excess of $25.0 million) intended to be covered thereby (to the extent perfection by filing, registration, recordation or possession is required by this Indenture Bridge Note or the Security Documents), (b) any of the Security Documents shall for whatever reason be terminated or cease to be in full force and effect (except for expiration in accordance with its terms or amendment, modification, waiver, termination or release in accordance with the terms of this Indenture Bridge Note) or (c) the enforceability of the Liens created by the Security Documents shall be contested by the Company, the Bridge Note Issuer or any Subsidiary Guarantor that is a Significant Subsidiary.

Schedule II-2

SCHEDULE III

MODIFICATIONS TO COLLATERAL
Modified Terms:
	
		
	Term
	Definition for purposes of the section entitled “Collateral” in the Bridge Note, except to the extent otherwise provided under “Modified Provisions” below

	Indenture
	Bridge Note

	Note Guarantee
	The guaranty of the Bridge Notes by a Guarantor or the Company pursuant to the section entitled “Bridge Note Guarantees” of the Bridge Note.

	Subsidiary Guarantors
	Each Subsidiary of the Company that is a party to the Bridge Note as a Guarantor or that executes a joinder to the Bridge Note providing for the guaranty of the payment of the Bridge Notes, or any successor obligor under its Note Guarantee pursuant to Section 11.04 of the Existing Indenture (as incorporated by reference in the section entitled “Bridge Note Guarantees” of the Bridge Note), in each case unless and until such Guarantor is released from its Note Guarantee pursuant to the Section 11.05 of the Existing Indenture (as incorporated by reference in the section entitled “Bridge Note Guarantees” of the Bridge Note).

	Trustee
	The Purchaser

	 
	 

	References to Sections and Articles
	Unless the context otherwise requires, such Section or Article as incorporated by reference in the Bridge Note

Modified Provisions:
		
	1.
	Section 10.01 is amended and restated in its entirety to read as follow:

“Section 10.01 Security Documents.
The due and punctual payment of the principal of, premium on, if any, and interest, if any, on, the Bridge Notes when and as the same shall be due and payable, whether on an interest payment date, at maturity, by acceleration, repurchase, redemption or otherwise, and interest on the overdue principal of, premium on, if any, and interest, if any (to the extent permitted by law), on the Bridge Notes and performance of all other obligations of the Bridge Note Issuer and the Company to the Purchaser Holders of Notes or the Trustee under this Bridge Note Indenture and the Bridge Notes (including, without limitation, the Note Guarantees), according to the terms hereunder or thereunder, are secured as provided in the Security Documents which the Bridge Note Issuer, the Company, and the Guarantors have previously has entered into simultaneously with the execution of this Indenture.  The Purchaser Each Holder of Notes, by its acceptance thereof, consents and agrees to the terms of the Security Documents (including, without limitation, the provisions providing for foreclosure and release of Collateral) as the same may be in effect or may be amended from time to time in accordance with its terms and authorizes and directs the Collateral Trustee to enter into the Security Documents and to perform its obligations and exercise its rights thereunder in accordance therewith.  The Company will deliver to the Purchaser Trustee copies of all documents delivered to the Collateral Trustee pursuant to the Security Documents, and will do or cause to be done all such acts and things as may be necessary or proper, or as may be required by the provisions of the Security Documents, to assure and confirm to the Purchaser Trustee and the Collateral Trustee the security interest in the Collateral contemplated hereby, by the Security Documents or any part thereof, as from time to time constituted, so as to render the same available for the security and benefit of this Bridge Note Indenture and of the Bridge Notes secured hereby, according to the intent and purposes herein expressed.  The Company will take, and will cause its Subsidiaries to take, upon request of the Purchaser Trustee, any and all actions reasonably required to cause the Security Documents to create and maintain, as security for the Obligations of the Bridge Note Issuer and the Company hereunder 

Schedule III-1

this Bridge Note (including, without limitation, the Note Guarantees), a valid and enforceable perfected first priority Lien in and on all the Collateral (excluding Excluded Assets) to the extent provided in the Security Documents, in favor of the Collateral Trustee for the benefit of the Purchaser Holders of Notes, superior to and prior to the rights of all third Persons and subject to no other Liens than Permitted Liens.”.
		
	2.
	Section 10.02 is amended and restated in its entirety to read as follow:

“Section 10.02    Release of Liens.
(a)    The Liens on the Collateral securing the Bridge Notes and the Note Guarantees will automatically be released:
(1)    upon payment in full of principal, interest and all other Obligations (other than contingent indemnity obligations) on the Bridge Notes and the Note Guarantees or satisfaction and discharge of this Indenture or defeasance (including covenant defeasance of the Notes);
(2)    in the case of such Liens securing the Note Guarantee of a Guarantor, upon release of a such Note Guarantee (with respect to the Liens securing such Note Guarantee granted by such Subsidiary Guarantor);
(3)    in connection with any sale, transfer or other disposition of Collateral to any Person other than the Company or any Subsidiary Guarantor (but excluding any transaction subject to Section 5.01 hereof Section 11.04 of the Existing Indenture (as incorporated by reference in the section entitled “Bridge Note Guarantees” of the Bridge Note)) that is not prohibited by this Bridge Note Indenture (with respect to the Lien on such Collateral); provided that, except in the case of any disposition in the ordinary course of business, upon such disposition and after giving effect thereto, no Default shall have occurred and be continuing, and the Company would be in compliance with the covenants set forth under Sections 4.03 and Section 4.04 of the Existing Indenture (as incorporated by reference in the section entitled “Covenants” of the Bridge Note) (calculated as if the disposition date was a date on which such covenant is required to be tested in such Section 4.04 hereof); provided, further, that any products or proceeds received by the Company or such Subsidiary Guarantor in respect of any such Collateral shall continue to constitute Collateral to the extent required by this Bridge Note Indenture and the Security Documents;
(4)    in whole or in part, with the consent of the Purchaser Holders of the requisite percentage of Notes in accordance with Article 9 hereof, including the release of all or substantially all of the Collateral if approved by Holders of at least 662/3% of the aggregate principal amount of the Notes; 
(5)    with respect to assets that become Excluded Assets; or
(6)    as contemplated by Section 4.1 and 4.4 of the Collateral Trust Agreement.
Each of the releases described in clauses 1, 2, 3 and 5 shall be effected by the Collateral Trustee upon receipt of appropriate notice of instruction, to the extent required, without the consent of Holders or any action on the part of the PurchaserTrustee.
(b)    Upon compliance by the Bridge Note Issuer, the Company or any Subsidiary Guarantor, as the case may be, with the conditions precedent required by this Bridge Note Indenture, the Purchaser Trustee or the Collateral Trustee shall promptly cause to be released and re-conveyed to the Bridge Note Issuer, the Company or the Subsidiary Guarantor, as the case may be, the released Collateral.”.

Schedule III-2

		
	3.
	The second paragraph of Section 10.03 is deleted in its entirety.

		
	4.
	Section 10.07 is amended and restated in its entirety to read as follow:

“Section 10.07    Termination of Security Interest.
Upon the full and final payment and performance of all Obligations (other than contingent indemnity obligations)  of the Bridge Note Issuer and the Company under this Bridge Note Indenture and the Bridge Notes or upon Legal Defeasance, Covenant Defeasance or satisfaction and discharge of this Indenture in accordance with Article 12 hereof, the Purchaser Trustee will, at the request of the Company, deliver a certificate to the Collateral Trustee stating that such Obligations have been paid in full, and instruct the Collateral Trustee to release the Liens pursuant to this Bridge Note Indenture and the Security Documents.”.

Schedule III-3

SCHEDULE IV
MODIFICATIONS TO NOTE GUARANTEES
Modified Terms:
	
		
	Term
	Definition for purposes of the section entitled “Bridge Note Guarantees” of the Bridge Note, except to the extent otherwise provided under “Modified Provisions” below

	Indenture
	Bridge Note

	Note
	The Bridge Note

	Note Guarantee
	The guaranty of the Bridge Notes by a Guarantor or the Company pursuant to the section entitled “Bridge Note Guarantees” of the Bridge Note.

	Subsidiary Guarantors
	Each Subsidiary of the Company that is a party to the Bridge Note as a Guarantor or that executes a joinder to the Bridge Note providing for the guaranty of the payment of the Bridge Notes, or any successor obligor under its Note Guarantee pursuant to Section 11.04 of the Existing Indenture (as incorporated by reference in the section entitled “Bridge Note Guarantees” of the Bridge Note), in each case unless and until such Guarantor is released from its Note Guarantee pursuant to the Section 11.05 of the Existing Indenture (as incorporated by reference in the section entitled “Bridge Note Guarantees” of the Bridge Note).

	Trustee
	The Purchaser

	 
	 

	References to Sections and Articles
	Unless the context otherwise requires, such Section or Article as incorporated by reference in the Bridge Note

Modified Provisions:
		
	1.
	Section 11.01 is amended and restated in its entirety to read as follow:

“Section 11.01    Note Guarantees.
(a)    Subject to this Article 11 the section entitled “Bridge Note Guarantees” of the Bridge Note, each of the Company and the Subsidiary Guarantors hereby, jointly and severally, unconditionally guarantees to the Purchaser each Holder of a Note authenticated and delivered by the Trustee and to the Trustee and its successors and assigns, irrespective of the validity and enforceability of this Bridge Note Indenture, the Bridge Notes or the obligations of the Bridge Note Issuer Company hereunder or thereunder, that:
(1)     the principal of, premium, if any, on, and interest, if any, on the Bridge Notes will be promptly paid in full when due, whether at maturity, by acceleration, redemption or otherwise, and interest on the overdue principal of, premium on, if any, and interest, if any, on, the Bridge Notes, if lawful, and all other obligations of the Bridge Note Issuer Company to the Purchaser Holders or the Trustee hereunder or thereunder will be promptly paid in full or performed, all in accordance with the terms hereof and thereof; and
(2)    in case of any extension of time of payment or renewal of any the Bridge Notes or any of such other obligations, that same will be promptly paid in full when due or performed in accordance with the terms of the extension or renewal, whether at stated maturity, by acceleration or otherwise.
Failing payment when due of any amount so guaranteed or any performance so guaranteed for whatever reason, the Company and the Subsidiary Guarantors will be jointly and severally obligated to pay the same 

Schedule IV-1

immediately.  Each of the Company and the Subsidiary Guarantors agrees that this is a guarantee of payment and not a guarantee of collection.
(b)    The Each of the Company and the Subsidiary Guarantors hereby agree that their obligations hereunder are unconditional, irrespective of the validity, regularity or enforceability of the Bridge Notes or this Bridge Note Indenture, the absence of any action to enforce the same, any waiver or consent by the Purchaser any Holder of the Notes with respect to any provisions hereof or thereof, the recovery of any judgment against the Bridge Note Issuer Company, any action to enforce the same or any other circumstance which might otherwise constitute a legal or equitable discharge or defense of a guarantor.  Each of the Company and the Subsidiary Guarantors hereby waives diligence, presentment, demand of payment, filing of claims with a court in the event of insolvency or bankruptcy of the Bridge Note Issuer Company, any right to require a proceeding first against the Bridge Note Issuer Company, protest, notice and all demands whatsoever and covenant that this Note Guarantee will not be discharged except by complete performance of the obligations contained in the Bridge Notes and this Bridge Note Indenture.
(c)    If the Purchaser any Holder or the Trustee is required by any court or otherwise to return to the Company, the Bride Note Issuer, the Subsidiary Guarantors or any custodian, trustee, liquidator or other similar official acting in relation to either any of the Company, the Bridge Note Issuer or the Subsidiary Guarantors, any amount paid by either any such Person to the Purchaser Trustee or such Holder, this Note Guarantee, to the extent theretofore discharged, will be reinstated in full force and effect.
(d)    Each of the Company and the Subsidiary Guarantors agrees that it will not be entitled to any right of subrogation in relation to the Purchaser Holders in respect of any obligations guaranteed hereby until payment in full of all obligations guaranteed hereby.  Each of the Company and the Subsidiary Guarantors further agrees that, as between the Company and the Subsidiary Guarantors, on the one hand, and the Purchaser Holders and the Trustee, on the other hand, (1) the maturity of the obligations guaranteed hereby may be accelerated as provided in Article 6 Section 8 hereof for the purposes of this Note Guarantee, notwithstanding any stay, injunction or other prohibition preventing such acceleration in respect of the obligations guaranteed hereby, and (2) in the event of any declaration of acceleration of such obligations as provided in Article 6 Section 8 hereof, such obligations (whether or not due and payable) will forthwith become due and payable by the Company and the Subsidiary Guarantors for the purpose of this Note Guarantee.  The Subsidiary Guarantors will have the right to seek contribution from any non-paying Subsidiary G guarantor so long as the exercise of such right does not impair the rights of the Purchaser Holders under the Note Guarantee.
		
	2.
	Section 11.03 is amended and restated in its entirety to read as follow:

“Section 11.03    Execution and Delivery of Note Guarantee.
To evidence its Note Guarantee set forth in Section 11.01 hereof the Existing Indenture (as incorporated by reference in the section entitled “Bridge Note Guarantees” of the Bridge Note), each of the Company and the Subsidiary Guarantors hereby agrees that a notation of such Note Guarantee substantially in the form attached as Exhibit E hereto will be endorsed by an Officer of such Subsidiary G guarantor on each the Bridge Note authenticated and delivered by the Trustee and that this Bridge Note Indenture will be executed on behalf of such Subsidiary G guarantor by one of its Officers.
Each of the Company and the Subsidiary Guarantors hereby agrees that its Note Guarantee set forth in Section 11.01 hereof the Existing Indenture (as incorporated by reference in the section entitled “Bridge Note Guarantees” of the Bridge Note) will remain in full force and effect notwithstanding any failure to endorse on each the Bridge Note a notation of such Note Guarantee.
In the event that the Company or any of its Restricted Subsidiaries creates or acquires any Domestic Subsidiary after the date of this Bridge Note Indenture, if required by Section 4.18 hereof the Existing Indenture (as incorporated by reference in the section entitled “Covenants” of the Bridge Note), the 

Schedule IV-2

Company will cause such Domestic Subsidiary to comply with the provisions of Section 4.18 hereof the Existing Indenture (as incorporated by reference in the section entitled “Covenants” of the Bridge Note) and this Article 6 Section of the Bridge Note, to the extent applicable. ”.
		
	3.
	Section 11.04 is amended and restated in its entirety to read as follow:

“Section 11.04    Subsidiary Guarantors May Consolidate, etc., on Certain Terms.
Except as otherwise provided in Section 11.05 hereof the Existing Indenture (as incorporated by reference in the section entitled “Bridge Note Guarantees” of the Bridge Note), no Subsidiary Guarantor may, directly or indirectly, sell, assign, transfer, convey, or otherwise dispose of all or substantially all of its assets to, or consolidate with or merge with or into (whether or not such Subsidiary Guarantor is the surviving Person) another Person, other than the Company, the Bridge Note Issuer or another Subsidiary Guarantor, unless:
(a)    immediately after giving effect to such transaction, no Default or Event of Default exists; and
(b)    either:
(1)    subject to Section 11.05 hereof the Existing Indenture (as incorporated by reference in the section entitled “Bridge Note Guarantees” of the Bridge Note), the Person acquiring the property in any such sale, assignment, transfer, conveyance or disposition or the Person formed by or surviving any such sale, assignment, transfer, conveyance, consolidation or merger unconditionally assumes all the obligations of that Subsidiary Guarantor under its Note Guarantee, this Bridge Note Indenture and the Security Documents on the terms set forth herein or therein, pursuant to a supplemental indenture and appropriate Security Documents in form and substance reasonably satisfactory to the Purchaser Trustee; or
(2)    the Net Proceeds of such sale, assignment, transfer, conveyance, or other disposition are applied in accordance with the applicable provisions of this Bridge Note Indenture, including without limitation, Section 4.12 hereof the Existing Indenture (as incorporated by reference in the section entitled “Covenants” of the Bridge Note).
In case of any such consolidation, merger, sale, assignment, transfer, or conveyance and upon the assumption by the successor Person, by supplemental indenture, executed and delivered to the Purchaser Trustee and satisfactory in form to the Purchaser Trustee, of the Note Guarantee endorsed upon the each the Bridge Notes and the due and punctual performance of all of the covenants and conditions of this Bridge Note Indenture to be performed by the Subsidiary Guarantor, such successor Person will succeed to and be substituted for the Subsidiary Guarantor with the same effect as if it had been named herein as a Subsidiary Guarantor.  Such successor Person thereupon may cause to be signed any or all of the Note Guarantees to be endorsed upon all of the Bridge Notes issuable hereunder which theretofore shall not have been signed by the Bridge Note Issuer Company and delivered to the Purchaser Trustee.  All the Note Guarantees so issued will in all respects have the same legal rank and benefit under this Bridge Note Indenture as the Note Guarantees theretofore and thereafter issued in accordance with the terms of this Bridge Note Indenture as though all of such Note Guarantees had been issued at the date of the execution hereof.
Except as set forth in Articles 4 and 5 hereof Article 6 Section 7, and notwithstanding clauses (b)(1) and (2) above, nothing contained in this Bridge Note Indenture or in any of the Bridge Notes will prevent any consolidation or merger of a Subsidiary Guarantor with or into the Company, the Bridge Note Issuer or another Subsidiary Guarantor, or will prevent any sale, assignment, transfer, or conveyance of the property of a Subsidiary Guarantor as an entirety or substantially as an entirety to the Company, the Bridge Note Issuer or another Subsidiary Guarantor. ”.

Schedule IV-3

		
	4.
	Section 11.05(d) is amended and restated in its entirety to read as follow:

“(d)    Upon payment in full of principal, interest and all other Obligations (other than contingent indemnity obligations) on the Bridge Note and the Note Guarantees Legal Defeasance or Covenant Defeasance in accordance with Article 8 hereof or satisfaction and discharge of this Indenture in accordance with Article 12 hereof, each Subsidiary Guarantor will be released and relieved of any obligations under its Note Guarantee.”.

Schedule IV-4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00265-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00265-of-00352.parquet"}]]